OTLK stock forecast for 2023 – 2027
Last updated: April 27, 2024
Are you interested in Outlook Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the OTLK stock price in 2022-2027. Is OTLK a good long term stock? When should I take profit in Outlook Therapeutics stock? Buy or sell stock? Will OTLK stock price go up? What are analysts’ forecasts for OTLK stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. OTLK stock returns are also predicted based on historical data.
According to our research, OTLK stock is a outstanding long-term investment. OTLK share price has been in a positive cycle for the past year. Outlook Therapeutics, Inc. stock trend is positive.
Outlook Therapeutics company info
| Industry | Biotechnology |
| Address | Building F, Iselin, NJ, 08852, United States |
| Website | https://www.outlooktherapeutics.com |
Forecasting
52 Week High: 4.15107 USD
52 Week Low: 1.37 USD
1 Year Forecast: 2.16874 USD
5 Year Forecast: 5.549 USD
Agilent Technologies info
Market Cap: 336.39M
52 Week Change: 0.385%
52 Week High: 4.26 USD
52 Week Low: 0.9285 USD
Beta: 2.36915
50 Day Moving Average: 1.37
90 Day Moving Average: 1.497
200 Day Moving Average: 1.99
Resistance Level: 1.45233
Pivot Point: 1.39392
Support Level: 1.33476
Enterprise Value: 0
Forward P/E: 0
Forward EPS: 0
Profit Margin: 0
Shares Outstanding: 0
EBITDA: 0
Held Percent Institutions: 0
PEG Ratio (5Y): 0
Trailing EPS: 0
Outlook Therapeutics stock forecasts for 2023-2027
| Date | Open Price | Close Price | Change |
Outlook Therapeutics Stock Forecast for 2023 | |||
| January 2023 | 2 | 2 | 0% |
| February 2023 | 1.98 | 2.04 | 3.03% |
| March 2023 | 2.02 | 4.08 | 101.98% |
| April 2023 | 3.96 | 2 | -49.49% |
| May 2023 | 2 | 3.06 | 53% |
| June 2023 | 2.97 | 3 | 1.01% |
| July 2023 | 3 | 3.06 | 2% |
| August 2023 | 3.03 | 3 | -0.99% |
| September 2023 | 3 | 3.06 | 2% |
| October 2023 | 3.03 | 2.94 | -2.97% |
| November 2023 | 3.06 | 3.03 | -0.98% |
| December 2023 | 3.06 | 3.06 | 0% |
Outlook Therapeutics Stock Forecast for 2024 | |||
| January 2024 | 3 | 2.97 | -1% |
| February 2024 | 2.94 | 2.94 | 0% |
| March 2024 | 2.97 | 4.95 | 66.67% |
| April 2024 | 4.9 | 3.03 | -38.16% |
| May 2024 | 3.06 | 4.08 | 33.33% |
| June 2024 | 4 | 3.96 | -1% |
| July 2024 | 4.08 | 4.04 | -0.98% |
| August 2024 | 3.96 | 4.08 | 3.03% |
| September 2024 | 4 | 4.08 | 2% |
| October 2024 | 3.96 | 4 | 1.01% |
| November 2024 | 3.96 | 3.96 | 0% |
| December 2024 | 3.92 | 4.08 | 4.08% |
Outlook Therapeutics Stock Forecast for 2025 | |||
| January 2025 | 3.96 | 4 | 1.01% |
| February 2025 | 4.08 | 4.04 | -0.98% |
| March 2025 | 3.92 | 5.94 | 51.53% |
| April 2025 | 6.06 | 3.96 | -34.65% |
| May 2025 | 3.96 | 5.05 | 27.53% |
| June 2025 | 4.9 | 4.95 | 1.02% |
| July 2025 | 5 | 5.1 | 2% |
| August 2025 | 5 | 5.1 | 2% |
| September 2025 | 4.95 | 5 | 1.01% |
| October 2025 | 4.9 | 5.05 | 3.06% |
| November 2025 | 4.95 | 4.9 | -1.01% |
| December 2025 | 5 | 4 | -20% |
Outlook Therapeutics Stock Forecast for 2026 | |||
| January 2026 | 4.08 | 4.08 | 0% |
| February 2026 | 5 | 4.9 | -2% |
| March 2026 | 5 | 6.93 | 38.6% |
| April 2026 | 7.07 | 4.9 | -30.69% |
| May 2026 | 5.1 | 6.06 | 18.82% |
| June 2026 | 6 | 5.94 | -1% |
| July 2026 | 6 | 6 | 0% |
| August 2026 | 6 | 5.88 | -2% |
| September 2026 | 6.06 | 5.1 | -15.84% |
| October 2026 | 4.9 | 5.1 | 4.08% |
| November 2026 | 5 | 4.9 | -2% |
| December 2026 | 5.1 | 5 | -1.96% |
Outlook Therapeutics Stock Forecast for 2027 | |||
| January 2027 | 4.95 | 5.1 | 3.03% |